• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic’s Q4 sales rise, earnings soar

Medtronic’s Q4 sales rise, earnings soar

May 25, 2010 By MassDevice staff

MDT logo

Medtronic Inc. (NYSE: MDT) closed out fiscal 2010 in fine shape, posting record fourth-quarter revenues and a profit surge of more than 826 percent.

The Fridley, Minn.-based medical device monolith posted net earnings of $954 million, or 86 cents per diluted share, on sales of $4.20 billion during the three months ended April 30. It’s the first time sales topped the $4 billion mark for Medtronic. TheQ4 2010 results compare to earnings of $103 million, or 9 cents per diluted share, on sales of $3.83 billion during the same period last year.

For the full year, Medtronic reported revenues of $15.82 billion, up 8.3 percent compared with $14.60 billion during fiscal 2009. Annual profits were $3.10 billion, or $2.79 per diluted share, compared with $2.07 billion, or $1.84 per diluted share, during the prior year.

Excluding about $788 million in charges related to acquisitions, charitable donations, legal expenses and tax adjustments, fourth-quarter and full-year net earnings rose 8 percent and 9 percent, respectively.

Medtronic said its cardiac rhythm disease management division gained on Boston Scientific Corp.’s (NYSE:BSX) loss, after its Natick, Mass.-based competitor began holding all shipments of its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators and pulled all inventory from the field after discovering that it missed a pair of filings with the Food & Drug Administration. Medtronic said fourth-quarter sales of its implantable cardioverter defibrillators rose 10 percent to $881 million, "due in part to a competitor’s suspension of sales," according to its earnings release.

St. Jude Medical Inc. (NYSE:STJ) also cashed in on what it called the "Boston Debacle" during its first quarter, reporting that its total cardiac rhythm management sales, including ICDs and pacemakers, jumped 11 percent to $752 million. The company estimates it generated $20 million to $25 million of those Q1 sales from BSX’s shipment hold and added two or three cents to its first-quarter profit of 73 cents a share ($238.6 million).

Medtronic said it expects revenue growth in the range of 5 percent to 8 percent for fiscal 2011, with diluted earnings per share in the range of $3.45 to $3.55.

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy